Skip to main content

Celebrating 20 Years of BMC Cancer

New Content Item (1)This year BMC Cancer is celebrating its 20th Anniversary. Since launching in 2001 we are proud to have become a leading Open Access journal in the oncology field, considering all areas of cancer research from cancer cell biology to epidemiology to cancer therapeutics and much more. We're looking back at our achievements and highlighting some of the most influential research published in the journal over the past two decades. 

Support and Guidance

Planning to submit a systematic review?

Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here

Submitting a study protocol?

Find out more about the journal's criteria and scope for study protocols here

Are cancer patients better off if they participate in clinical trials?

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.


  1. Authors: Miguel Cordova-Delgado, María Loreto Bravo, Elisa Cumsille, Charlotte N. Hill, Matías Muñoz-Medel, Mauricio P. Pinto, Ignacio N. Retamal, María A. Lavanderos, Juan Francisco Miquel, Maria Rodriguez-Fernandez, Yuwei Liao, Zhiguang Li, Alejandro H. Corvalán, Ricardo Armisén, Marcelo Garrido, Luis A. Quiñones…

    Content type: Research

Featured video: Microparticles, breast cancer's secret weapon?

Your browser needs to have JavaScript enabled to view this video

Read the article


BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.

Call for submissions: 'Targeted Therapy' Collection

The Editors of BMC Cancer and BMC Medicine invite of submissions to our ‘Targeted Therapy’ cross journal collection. Guest edited by Prof. Min Li (University of Oklahoma Health Sciences Center, USA) and Dr. Yanis Boumber (The Northwestern University, USA). 

We advise to submit by 1st August 2021 if you would like your manuscript to be ready for the launch date. 

Call for Submissions: 'Microbiome and Cancer' Collection

The Editors of BMC Cancer, BMC Microbiology and Microbiome invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin. 

Open for submissions until 30th September 2021. 

BMC Series Focus Issues

September: Patient and public involvement in research

In recognition of World Patient Safety Awareness day on 17th September, the BMC Series presents a focus issue on Patient and Public Involvement (PPI) in research.  We have collated free-to-read content from across our journals - showcasing patient perspectives, research into the study of PPI, and engaging public partners as co-authors in research.

August: Breastfeeding

In celebration of World Breastfeeding week in the beginning of August,  the BMC Series presents a focus issue on Breastfeeding.  We have  collated open-access content from across our journals to highlight research into breastfeeding behaviors and care for lactating women, infant and child health, biology of breastfeeding, and more.

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last 6 months!

Editorial: Nobel Prize Cancer Immunotherapy!

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Speed
    79 days to first decision for reviewed manuscripts only
    55 days to first decision for all manuscripts
    170 days from submission to acceptance
    16 days from acceptance to publication

    Citation Impact
    4.430 - 2-year Impact Factor
    4.372 - 5-year Impact Factor
    1.218 - Source Normalized Impact per Paper (SNIP)
    1.358 - SCImago Journal Rank (SJR)

    2,117 Altmetric Mentions